Felipe
Villacampa Aubá
Consultor Médico
Hospital Ramón y Cajal
Madrid, EspañaPublicacions en col·laboració amb investigadors/es de Hospital Ramón y Cajal (2)
2024
-
Chemoablation with UGN-102 in intermediate-risk non-muscle invasive bladder cancer, are we there yet?
Translational Andrology and Urology
2021
-
Quality of life and adverse events in patients with nonmuscle invasive bladder cancer receiving adjuvant treatment with BCG, MMC, or chemohyperthermia
Urologic Oncology: Seminars and Original Investigations, Vol. 39, Núm. 1, pp. 76.e9-76.e14